Cure Alzheimer's Fund Cure Alzheimer's Fund

Evaluation of Sleep-EEG in Transgenic Mice

2017

PsychoGenics will carry out EEG readings of sleeping and awake ACE1 transgenic mice containing genetic variants identified by Genome-Wide Association Studies (GWAS) for their impact on Alzheimer’s disease risk. This research is being conducted in conjunction with Robert Vassar, Ph.D.’s project “Molecular and Cellular Mechanisms of ACE1 Variant in Alzheimer’s Disease.”

PsychoGenics Studies of Alternative Neurodegenerative Pathways Translational

Funding to Date

$27,500

Focus

Studies of Alternative Neurodegenerative Pathways, Translational

Researchers

PsychoGenics

Related Content:


Deciphering and Restoring Computational Setpoints in Alzheimer’s Disease Through Sleep-Enhanced Network Homeostasis Keith Hengen 2024-01-12 Morphological, Electrophysiological and Transcriptional Characterization of Single Neurons from Resilient and Susceptible Models of Human Alzheimer’s Disease Catherine Kaczorowski Shannon Moore 2024-01-10 Neuronal Mechanisms Driving Synapse Loss in Alzheimer’s Disease Martin Kampmann 2024-01-10 A Multimodality Study on the Lipid Molecular Basis of Obesity and Its Roles in Regulating Alzheimer’s Pathogenesis for Developing Potential Targeted Interventions Stephen T.C. Wong 2024-01-10 Restore Meningeal Lymphatic Drainage to Alleviate White Matter Damage and Cerebral Amyloid Angiopathy in a Model of Alzheimer’s Disease Sandro Da Mesquita 2023-12-09 Circadian Desynchrony, Glial Dysfunction and Alzheimer’s Disease Pathogenesis Erik S. Musiek 2023-12-09 Oligodendroglial Dynamics and Myelination in Alzheimer’s Disease Erin M. Gibson 2023-12-08 Scaling the Divide in Alzheimer’s Disease: An Integrated Molecular, Cellular and Network-Level Study Marc Aurel Busche Samuel Harris 2023-12-08